{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:38:18Z","timestamp":1790109498381,"version":"4.0.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1097\/dad.0b013e31828a2d54","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T04:39:27Z","timestamp":1367901567000},"page":"138-144","source":"Crossref","is-referenced-by-count":29,"title":["Epigenetic Modifications in Cutaneous Malignant Melanoma"],"prefix":"10.1097","volume":"37","author":[{"given":"Panagiotis","family":"Kampilafkos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Melachrinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinovia","family":"Kefalopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lakoumentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Sotiropoulou-Bonikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0025-6196(11)61033-1","article-title":". Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.","volume":"82","author":"Markovic","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","article-title":". Identification of cells initiating human melanomas.","volume":"451","author":"Schatton","year":"2008","journal-title":"Nature"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/cr.2011.24","article-title":"Cancer epigenetics: linking basic biology to clinical medicine.","volume":"21","author":"Tsai","year":"2011","journal-title":"Cell Res"},{"key":"R4-7-20210202","first-page":"147","article-title":"Cancer stem cells: problems for therapy J Pathol.","volume":"223","author":"Alison","year":"2011","journal-title":""},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modificationsmiswritten, misinterpreted and mis-erased in human cancers.","volume":"10","author":"Chi","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer.","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/138920107783018372","article-title":"Epigenetic lesions in malignant melanoma.","volume":"8","author":"Schwabe","year":"2007","journal-title":"Curr Pharm Biotechnol"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":". A bivalent chromatin structure marks key developmental genes in embryonic stem cells.","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/bjc.2011.551","article-title":"The role of EZH2 in tumuor progression.","volume":"106","author":"Chang","year":"2012","journal-title":"Br J Cancer"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","article-title":". EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.","volume":"24","author":"Bachmann","year":"2006","journal-title":"J Clin Oncol"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1600-0560.2006.00678.x","article-title":". Expression of polycomb group protein EZH2 in nevi and melanoma.","volume":"34","author":"McHugh","year":"2007","journal-title":"J Cutan Pathol"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","article-title":". EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21CDKN1A expression.","volume":"9","author":"Fan","year":"2011","journal-title":"Mol Cancer Res"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4161\/epi.6.11.18021","article-title":". Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer.","volume":"6","author":"Iliou","year":"2011","journal-title":"Epigenetics"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrc2931","article-title":"Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.","volume":"10","author":"Mills","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/zeb.2009.0612","article-title":". Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation.","volume":"6","author":"Anelli","year":"2009","journal-title":"Zebrafish"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.2475","article-title":"Gastrointestinal stem cells in development and cancer.","volume":"217","author":"Brabletz","year":"2009","journal-title":"J Pathol"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":". Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.3748\/wjg.15.5898","article-title":"Invasive front of colorectal cancer: dynamic interface of pro-anti-tumor factors.","volume":"15","author":"Zlobec","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/stem.467","article-title":". Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells.","volume":"28","author":"Battula","year":"2010","journal-title":"Stem Cells"},{"key":"R21-7-20210202","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrc1694","article-title":". Opinion: migrating cancer stem cellsan integrated concept of malignant tumour progression.","volume":"5","author":"Brabletz","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1479-5876-8-56","article-title":". Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.","volume":"8","author":"Sigalotti","year":"2010","journal-title":"J Transl Med"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3748\/wjg.v16.i6.732","article-title":". ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.","volume":"16","author":"Hostettler","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2008.05.163","article-title":". Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431.","volume":"373","author":"Atsumi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/stem.92","article-title":". Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma.","volume":"27","author":"He","year":"2009","journal-title":"Stem Cells"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.molcel.2011.07.012","article-title":". Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition.","volume":"43","author":"Wu","year":"2011","journal-title":"Mol Cell"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1038\/onc.2010.234","article-title":". Requirement of the histone demethylase LDS1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.","volume":"29","author":"Lin","year":"2010","journal-title":"Oncogene"},{"key":"R28-7-20210202","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/carcin\/bgp314","article-title":"The Bmi-1 polycomb protein antagonizes the ()-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.","volume":"31","author":"Balasubramanian","year":"2010","journal-title":"Carcinogenesis"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/cancers3011383","article-title":". Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer.","volume":"1","author":"Blair","year":"2011","journal-title":"Cancers (Basel)"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1158\/0008-5472.CAN-11-0896","article-title":". Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biocel.2011.01.005","article-title":"Enhancer of zeste homolog 2: a potential target for tumor therapy.","volume":"43","author":"Xiao","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":". Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0b013e31828a2d54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:19:04Z","timestamp":1620937144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201502000-00007"}},"subtitle":["EZH2, H3K4me2, and H3K27me3 Immunohistochemical Expression is Enhanced at the Invasion Front of the Tumor"],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31828a2d54","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}